RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tianjin Pharmaceutical Da Ren Tang Group Corp - Stock

Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend 2024

Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend

1.12 CNY

Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend yield

3.06 %

Ticker

600329.SS

ISIN

CNE000001808

How much dividend does Tianjin Pharmaceutical Da Ren Tang Group Corp 2024 pay?

According to the latest status from June 2024, Tianjin Pharmaceutical Da Ren Tang Group Corp paid a total of 1.12 CNY per share in dividends within the last 12 months. With the current Tianjin Pharmaceutical Da Ren Tang Group Corp price of 36.66 CNY, this corresponds to a dividend yield of 3.06 %. A dividend is paid times per year.

3.06 % Dividend Yield=
1.12 CNY Dividend
36.66 CNY Stock Price

Historical Tianjin Pharmaceutical Da Ren Tang Group Corp Dividends

A dividend is paid times per year. Last year, the payout months were and July.

PaydateDividend
7/6/20231.12
7/2/20220.5
7/24/20210.3
7/24/20200.3
8/15/20190.22
8/13/20180.2
8/14/20170.15
1/23/20170.1
8/15/20160.15
7/1/20150.15
8/15/20140.05
1/19/20140.1
1/13/20130.2
8/6/20110.2
7/6/20060.15
7/29/20050.15
8/22/20040.15
8/28/20030.15
8/23/20020.17
1

Tianjin Pharmaceutical Da Ren Tang Group Corp Stock Dividend

Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Tianjin Pharmaceutical Da Ren Tang Group Corp provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Tianjin Pharmaceutical Da Ren Tang Group Corp’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Tianjin Pharmaceutical Da Ren Tang Group Corp's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend History

DateTianjin Pharmaceutical Da Ren Tang Group Corp Dividend
2026e1.21 CNY
2025e1.21 CNY
2024e1.21 CNY
20231.12 CNY
20220.5 CNY
20210.3 CNY
20200.3 CNY
20190.22 CNY
20180.2 CNY
20170.15 CNY
20160.25 CNY
20150.15 CNY
20140.05 CNY
20130.1 CNY
20120.2 CNY
20110.2 CNY
20060.08 CNY
20050.08 CNY
20040.08 CNY

Is the Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend Safe?

Tianjin Pharmaceutical Da Ren Tang Group Corp has been increasing the dividend for 2 years.

Over the past 10 years, Tianjin Pharmaceutical Da Ren Tang Group Corp has increased it by an annual 27.327 %.

Over a five-year period, the distribution increased by 41.136%.

Analysts expect a Dividend Increase of 4.065% for the current fiscal year.

Tianjin Pharmaceutical Da Ren Tang Group Corp Stock Payout Ratio

Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Tianjin Pharmaceutical Da Ren Tang Group Corp represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Tianjin Pharmaceutical Da Ren Tang Group Corp could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Tianjin Pharmaceutical Da Ren Tang Group Corp's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Tianjin Pharmaceutical Da Ren Tang Group Corp Payout Ratio History

DateTianjin Pharmaceutical Da Ren Tang Group Corp Payout ratio
2026e37.84 %
2025e39.64 %
2024e37.23 %
202336.64 %
202245.05 %
202130 %
202034.88 %
201927.16 %
201827.4 %
201724.19 %
201645.45 %
201525.42 %
201410.42 %
201320.83 %
201233.33 %
201160.61 %
201036.64 %
200936.64 %
200836.64 %
200736.64 %
2006-14.42 %
200568.18 %
200483.33 %

Dividend Details

Understanding Tianjin Pharmaceutical Da Ren Tang Group Corp's Dividend Distributions

Tianjin Pharmaceutical Da Ren Tang Group Corp’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Tianjin Pharmaceutical Da Ren Tang Group Corp's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Tianjin Pharmaceutical Da Ren Tang Group Corp's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Tianjin Pharmaceutical Da Ren Tang Group Corp’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Tianjin Pharmaceutical Da Ren Tang Group Corp Aktienanalyse

What does Tianjin Pharmaceutical Da Ren Tang Group Corp do?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is one of the leading pharmaceutical companies in China. It was founded in 1994 and is headquartered in the city of Tianjin in the northern part of the country. Zhongxin is a publicly traded company and employs over 6,000 employees. The business model of Zhongxin is diversified and includes manufacturing, research and development, sales, and marketing of pharmaceuticals and medical devices. The company strives to provide its customers with high-quality products and services and operates in various specialized areas. One of Zhongxin's main divisions is the manufacturing of pharmaceutical products. The company specializes in the production of cardiology, gastroenterology, oncology, and traditional Chinese medicines. Zhongxin operates multiple production facilities in China and has a productive R&D department focused on drug development. Another important part of Zhongxin's business is the distribution of its products. The company operates several distribution centers in China and is also increasing its presence in international markets. Distribution is done either directly to end customers or through intermediaries. In addition to the sale of medications, Zhongxin is also involved in medical wholesale activities, including retail and delivery of medical equipment and instruments. The company is capable of providing all types of medical devices and instruments from imaging and diagnostics to surgical instruments and implants. Zhongxin also has a specialized chemicals and raw materials division focused on the production of pharmaceutical active ingredients and intermediates. This gives the company additional control over the quality of its products as it is able to produce raw materials itself. The company is always seeking new innovations and heavily investing in research and development. In recent times, Zhongxin has invested in the development of biotech and nucleic acid therapies and intends to develop further innovative treatment methods. Zhongxin has also developed a strong presence in international markets in recent years. It has subsidiaries in several countries including the USA, Australia, Japan, and Europe. The company engages in joint ventures and strategic partnerships to enhance its raw material procurement and expand its reach internationally. Overall, Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a significant player in the pharmaceutical industry in China and on the international stage. The company has established a reputation as a reliable producer of high-quality medical products and services and continues to strive for success through innovation and expansion. Tianjin Pharmaceutical Da Ren Tang Group Corp is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Tianjin Pharmaceutical Da Ren Tang Group Corp Stock

How much dividend does Tianjin Pharmaceutical Da Ren Tang Group Corp pay?

Over the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corp paid a dividend of 1.12 CNY . This corresponds to a dividend yield of about 3.06 %. For the coming 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corp is expected to pay a dividend of 1.21 CNY.

What is the dividend yield of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The current dividend yield of Tianjin Pharmaceutical Da Ren Tang Group Corp is 3.06 %.

When does Tianjin Pharmaceutical Da Ren Tang Group Corp pay dividends?

Tianjin Pharmaceutical Da Ren Tang Group Corp pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp paid dividends every year for the past 16 years.

What is the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp?

For the upcoming 12 months, dividends amounting to 1.21 CNY are expected. This corresponds to a dividend yield of 3.3 %.

In which sector is Tianjin Pharmaceutical Da Ren Tang Group Corp located?

Tianjin Pharmaceutical Da Ren Tang Group Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tianjin Pharmaceutical Da Ren Tang Group Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp from 6/6/2023 amounting to 1.12 CNY, you needed to have the stock in your portfolio before the ex-date on 6/6/2023.

When did Tianjin Pharmaceutical Da Ren Tang Group Corp pay the last dividend?

The last dividend was paid out on 6/6/2023.

What was the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp in the year 2023?

In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp distributed 0.5 CNY as dividends.

In which currency does Tianjin Pharmaceutical Da Ren Tang Group Corp pay out the dividend?

The dividends of Tianjin Pharmaceutical Da Ren Tang Group Corp are distributed in CNY.

Andere Kennzahlen von Tianjin Pharmaceutical Da Ren Tang Group Corp

Our stock analysis for Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.